| Name | Title | Contact Details |
|---|
UnisLink is a healthcare technology company dedicated to helping healthcare providers optimize their business and focus on quality patient care. They offer a single platform that combines premium data analytics capabilities, state-of-the-art technology...
Honest1, a national full-service auto care company, is passionate about putting customers first. Its customer-centric, transparent approach assures every customer is thoroughly educated on the systems and services necessary to keep their vehicles in the best running condition. Honest1 centers are family-friendly with clean and upscale waiting areas, Internet cafes, childrens play areas, comfortable leather chairs and couches, HDTVs and complimentary beverage stations. In addition to putting its customers first, Honest1 Auto Care performs H-1 ESA Quality checks at each of its locations to ensure performance is environmentally sustainable.
Founded in 1999, YourCFOtoGo has provided services ranging from daily bookkeeping to executive-level advisory and consulting to clients in various industries. Although we have grown exponentially since our inception, our commitment to excellence is now and always will be the core of our business model.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
COVE Animal Health is a veterinarian-led network of veterinary hospitals providing integrated primary care, emergency, and specialty services across several states in the Northeastern United States, including Connecticut, Maine, Massachusetts, and Pennsylvania. Originally founded in 1937 as Pieper Veterinary in Middletown, CT, COVE has grown into a multi-state network with over 1,000 team members and four hospital systems. COVE offers a comprehensive range of veterinary services, including routine wellness care, 24/7 emergency services, and advanced specialty care in areas such as internal medicine, ophthalmology, and surgery. The company operates a hub-and-spoke model that ensures seamless coordination among its hospitals, enhancing collaboration and resource sharing. COVE is committed to maintaining local ownership and community connections while fostering a culture of mentorship and professional development for veterinary teams.